Brief: Cantargia Expands CIRIFOUR Trial

Cantargia AB

19/08/2021 11:07

Aug 19 (Reuters) - Cantargia AB  CANTA.ST :
    * CANTARGIA EXPANDS CIRIFOUR TRIAL AFTER SUCCESSFUL
COMPLETION OF
RECRUITMENT IN THE PEMBROLIZUMAB COMBINATION ARM
    * PRELIMINARY RESULTS SHOW THAT COMBINATION IS
WELL-TOLERATED AND
ARE PLANNED TO BE REPORTED IN Q4 2021.
    * TREATMENT OF FIRST PATIENT IN THIS NEW ARM IS EXPECTED TO
START
IN Q4 2021 AND PLAN IS TO RECRUIT UP TO 30 PATIENTS.

Source text for Eikon:  ID:nWkr2mSyhj 
Further company coverage:  CANTA.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))